Literature DB >> 18564998

Reduced cold pain tolerance in chronic pain patients following opioid detoxification.

Jarred Younger1, Peter Barelka, Ian Carroll, Kim Kaplan, Larry Chu, Ravi Prasad, Ray Gaeta, Sean Mackey.   

Abstract

OBJECTIVE: One potential consequence of chronic opioid analgesic administration is a paradoxical increase of pain sensitivity over time. Little scientific attention has been given to how cessation of opioid medication affects the hyperalgesic state. In this study, we examined the effects of opioid tapering on pain sensitivity in chronic pain patients.
DESIGN: Twelve chronic pain patients on long-term opioid analgesic treatment were observed in a 7- to 14-day inpatient pain rehabilitation program, with cold pain tolerance assessed at admission and discharge. The majority of participants were completely withdrawn from their opioids during their stay. OUTCOME MEASURES: We hypothesized that those patients with the greatest reduction in daily opioid use would show the greatest increases in pain tolerance, as assessed by a cold pressor task.
RESULTS: A linear regression revealed that the amount of opioid medication withdrawn was a significant predictor of pain tolerance changes, but not in the direction hypothesized. Greater opioid reduction was associated with decreased pain tolerance. This reduction of pain tolerance was not associated with opioid withdrawal symptoms or changes in general pain.
CONCLUSIONS: These findings suggest that the withdrawal of opioids in a chronic pain sample leads to an acute increase in pain sensitivity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18564998      PMCID: PMC2751584          DOI: 10.1111/j.1526-4637.2008.00475.x

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  31 in total

1.  A pilot study into the problematic use of opioid analgesics in chronic non-cancer pain patients.

Authors:  David T Cowan; Laurie Allan; Peter Griffiths
Journal:  Int J Nurs Stud       Date:  2002-01       Impact factor: 5.837

Review 2.  Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy.

Authors:  Jianren Mao
Journal:  Pain       Date:  2002-12       Impact factor: 6.961

3.  Comment on: Doverty et al, Hyperalgesic responses in methadone maintenance patients (Pain 2001;90;91-6).

Authors:  David J Clark
Journal:  Pain       Date:  2002-10       Impact factor: 6.961

4.  Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: a sensitization process.

Authors:  E Célèrier; J P Laulin; J B Corcuff; M Le Moal; G Simonnet
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

5.  A murine model of opioid-induced hyperalgesia.

Authors:  X Li; M S Angst; J D Clark
Journal:  Brain Res Mol Brain Res       Date:  2001-01-31

6.  Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent.

Authors:  P Compton; V C Charuvastra; W Ling
Journal:  Drug Alcohol Depend       Date:  2001-07-01       Impact factor: 4.492

7.  Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine.

Authors:  E Célèrier; C Rivat; Y Jun; J P Laulin; A Larcher; P Reynier; G Simonnet
Journal:  Anesthesiology       Date:  2000-02       Impact factor: 7.892

8.  Significant pain reduction in chronic pain patients after detoxification from high-dose opioids.

Authors:  Michael J Baron; Paul W McDonald
Journal:  J Opioid Manag       Date:  2006 Sep-Oct

9.  Hyperalgesia during opioid abstinence: mediation by glutamate and substance p.

Authors:  Xiangqi Li; J David Clark
Journal:  Anesth Analg       Date:  2002-10       Impact factor: 5.108

10.  Sustained morphine exposure induces a spinal dynorphin-dependent enhancement of excitatory transmitter release from primary afferent fibers.

Authors:  Luis R Gardell; Ruizhong Wang; Shannon E Burgess; Michael H Ossipov; Todd W Vanderah; T Philip Malan; Josephine Lai; Frank Porreca
Journal:  J Neurosci       Date:  2002-08-01       Impact factor: 6.167

View more
  9 in total

1.  Patient Perspectives Associated with Intended Duration of Buprenorphine Maintenance Therapy.

Authors:  Brandon S Bentzley; Kelly S Barth; Sudie E Back; Garrett Aronson; Sarah W Book
Journal:  J Subst Abuse Treat       Date:  2015-04-07

2.  [Altered pain thresholds during and after opioid withdrawal in patients with chronic low back pain].

Authors:  H Wang; N Weinsheimer; M Akbar; M Schiltenwolf
Journal:  Schmerz       Date:  2010-06       Impact factor: 1.107

3.  Psycho-physiological response to pain among individuals with comorbid pain and opioid use disorder: Implications for patients with prolonged abstinence.

Authors:  Amy Wachholtz; Gerardo Gonzalez; Douglas Ziedonis
Journal:  Am J Drug Alcohol Abuse       Date:  2019-06-27       Impact factor: 3.829

4.  Benefits and Harms of Long-term Opioid Dose Reduction or Discontinuation in Patients with Chronic Pain: a Rapid Review.

Authors:  Katherine Mackey; Johanna Anderson; Donald Bourne; Emilie Chen; Kim Peterson
Journal:  J Gen Intern Med       Date:  2020-11-03       Impact factor: 5.128

5.  Multidisciplinary care for opioid dose reduction in patients with chronic non-cancer pain: A systematic realist review.

Authors:  Abhimanyu Sud; Alana Armas; Heather Cunningham; Shawn Tracy; Kirk Foat; Navindra Persaud; Fardous Hosseiny; Sylvia Hyland; Leyna Lowe; Erin Zlahtic; Rhea Murti; Hannah Derue; Ilana Birnbaum; Katija Bonin; Ross Upshur; Michelle L A Nelson
Journal:  PLoS One       Date:  2020-07-27       Impact factor: 3.240

6.  Efficacy of interventions to reduce long term opioid treatment for chronic non-cancer pain: systematic review and meta-analysis.

Authors:  Nicholas Avery; Amy G McNeilage; Fiona Stanaway; Claire E Ashton-James; Fiona M Blyth; Rebecca Martin; Ali Gholamrezaei; Paul Glare
Journal:  BMJ       Date:  2022-04-04

7.  Repeated Morphine Administration Increases TRPV1 mRNA Expression and Autoradiographic Binding at Supraspinal Sites in the Pain Pathway.

Authors:  Thi-Lien Nguyen; Yun-Son Nam; Seok-Yong Lee; Choon-Gon Jang
Journal:  Biomol Ther (Seoul)       Date:  2022-05-26       Impact factor: 4.231

Review 8.  A review of trial and real-world data applying elements of a realist approach to identify behavioural mechanisms supporting practitioners to taper opioids.

Authors:  Debi Bhattacharya; Hattie Whiteside; Emma Tang; Kumud Kantilal; Yoon Loke; Bethany Atkins; Caroline Hill
Journal:  Br J Clin Pharmacol       Date:  2022-05-13       Impact factor: 3.716

9.  Withdrawal-associated injury site pain (WISP): a descriptive case series of an opioid cessation phenomenon.

Authors:  Launette Marie Rieb; Wendy V Norman; Ruth Elwood Martin; Jonathan Berkowitz; Evan Wood; Ryan McNeil; M-J Milloy
Journal:  Pain       Date:  2016-12       Impact factor: 7.926

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.